Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

887053

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential savings to be accrued to the public purse of the return of unused medicines to the NHS.
tabling member constituency	Birmingham, Edgbaston
tabling member printed	Preet Kaur Gill
uin	136621
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>The Department has made no assessment of the potential savings to be accrued to the public purse from the return of unused medicines to the National Health Service.</p><p> </p><p>The Department is concerned about wastage from unused medicines and is keen to minimise unnecessary extra costs. However, it does not promote the reuse of medicines that have left the pharmacy and been returned to a pharmacy by patients, as it is not possible to guarantee the quality of a returned medicine on physical inspection alone. When medicines are returned from patients’ homes, there is no way of knowing how the medicines have been stored or handled.</p><p> </p><p>The Royal Pharmaceutical Society publication, ‘Medicines Ethics and Practice - The professional guide for pharmacists (July 2017)’ states, “patients should be advised that unused, unwanted medicines should be returned to a pharmacy for safe disposal”</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:32:09 answering member 4067 label Biography information for Steve Brine
tabling member	4603 label Biography information for Preet Kaur Gill

887057

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coagadex
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether Coagadex is available on the NHS for patients with the hereditary factor X deficiency bleeding disorder; and if he will make a statement.
tabling member constituency	Leeds North East
tabling member printed	Fabian Hamilton
uin	136625
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>At present, NHS England does not routinely commission Coagadex for any indication.</p><p> </p><p>A commissioning policy proposal for the prescribing of Coagedex for patients with the hereditary factor X deficiency bleeding disorder has been developed. The Clinical Priorities Advisory Group (CPAG) makes recommendations on NHS England's approach to commissioning services, treatments and technologies, and considers which of these should be prioritised for investment. The CPAG will make its recommendations regarding the commissioning of Coagadex to NHS England in May 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 26/04/2018 10:24:10 answering member 4067 label Biography information for Steve Brine
tabling member	415 label Biography information for Fabian Hamilton

887080

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the options for procuring glucose monitoring devices for people with diabetes in order to ensure that those devices are procured effectively.
tabling member constituency	Knowsley
tabling member printed	Mr George Howarth
uin	136648
answer	answer is ministerial correction date of answer 25/04/2018 answer text <p>Whilst the National Health Service is committed to providing access to new drugs and medical technologies, it is the responsibility of clinical commissioning groups (CCGs) to determine how funds are allocated for their local population. CCGs are responsible for commissioning diabetes services. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, and take into account national guidelines. This would apply to glucose monitoring devices, which would need to be both licensed and assessed for clinical and cost-effectiveness.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 25/04/2018 10:56:42 answering member 4067 label Biography information for Steve Brine
tabling member	481 label Biography information for Sir George Howarth

887120

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Databases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of ring-fencing part of the rebate paid by the pharmaceutical industry in the next iteration of the Pharmaceutical Price Regulation Scheme for the purposes of investing in NHS data infrastructure.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	136685
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>Under the current Pharmaceutical Price Regulation Scheme (PPRS) all payments go back into spending on improving patients’ health and care. Following normal Government accounting rules, there is no separately identified ring-fenced funding stream associated with the PPRS payment.</p><p> </p><p>Informal discussions have already begun with industry regarding future medicines pricing arrangements. Formal negotiations will begin shortly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:32:53 answering member 4067 label Biography information for Steve Brine
tabling member	1439 label Biography information for Norman Lamb

887230

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of the increase in NHS dental charges from 1 April 2018 on people’s (a) ability to pay for such services and (b) decision to access such services.
tabling member constituency	Birmingham, Northfield
tabling member printed	Richard Burden
uin	136794
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>Prior to the decision to uplift patient charges, the Department undertook an equality analysis and impact assessment. These have been published and can be found at the following link:</p><p> </p><p><a href="http://www.legislation.gov.uk/uksi/2018/336/resources" target="_blank">http://www.legislation.gov.uk/uksi/2018/336/resources</a></p><p> </p><p>The current exemption and charge remission arrangements are intended to ensure that individuals are not deterred from obtaining any necessary treatment on financial grounds.</p><p> </p><p>There has been no change to the exemption arrangements as a result of current increases to National Health Service dental charges. NHS dental treatment remains free for those under the age of 18, those under the age of 19 and in full-time education, pregnant women, those who have had a baby in the previous 12 months and those on low incomes.</p><p> </p><p>In addition, adults who are not in receipt of qualifying benefits, but are on a low income, may qualify for full or partial help with charges through the NHS Low Income Scheme.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 26/04/2018 10:19:38 answering member 4067 label Biography information for Steve Brine
tabling member	301 label Biography information for Richard Burden

887281

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Life Expectancy: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will place in the Library all reports and data analyses his Department has produced which relate to life expectancy in each of the last eight years; and whether his Department plans to publish such data and analyses in the future.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	136845
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>A record of all Departmental publications reports and data analyses relating to life expectancy in the eight years is not held centrally and to collate all relevant documents would incur disproportionate cost.</p><p> </p><p>Public Health England is planning to publish analyses of life expectancy in the future, including in the next Health Profile for England which will be released in September 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:35:31 answering member 4067 label Biography information for Steve Brine
tabling member	534 label Biography information for Chris Ruane

887282

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Life Expectancy: Females
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to Office for National Statistics data on life expectancies, what assessment he has made of the reasons for the change in life expectancy at birth for females between 2009-11 and 2014-16 in (a) Uttesford, (b) Cheltenham, (c) Castle Point, (d) Purbeck, (e) East Staffordshire, and (f) Tendring.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	136846
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>Public Health England (PHE) is working with academic partners to produce a model to help determine underlying trends in life expectancy for all English local authorities. This model will take into account the revised population estimates recently issued by the Office for National Statistics. PHE expects to be able to report on the results of this analysis later in 2018.</p><p> </p><p>Care needs to be taken when analysing and interpreting local authority data as their small populations mean their life expectancy is subject to fluctuations from year to year.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:33:46 answering member 4067 label Biography information for Steve Brine
tabling member	534 label Biography information for Chris Ruane

887287

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many cases of (a) tuberculosis, (b) rickets and (c) measles were recorded in each month in the last 12 months.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	136851
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>The data for cases of tuberculosis (TB) for the last 12 months are not available in the format requested.</p><p> </p><p>The most recent provisional data for the number and rate of TB cases notified in England in 2017 are available here:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/693328/TB_ad_hoc_statistics_March_2018.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/693328/TB_ad_hoc_statistics_March_2018.pdf</a></p><p>Data on the number of cases of rickets recorded in England for each of the last 12 months are not available in the format requested.</p><p> </p><p>The latest data available on the number of confirmed cases of rickets in England can be found here:</p><p><a href="https://digital.nhs.uk/data-and-information/find-data-and-publications/supplementary-information/2018-supplementary-information-files/count-of-finished-admission-episodes-faes-with-a-primary-or-secondary-diagnosis-of-scurvy-rickets-and-malnutrition-supplementary-information" target="_blank">https://digital.nhs.uk/data-and-information/find-data-and-publications/supplementary-information/2018-supplementary-information-files/count-of-finished-admission-episodes-faes-with-a-primary-or-secondary-diagnosis-of-scurvy-rickets-and-malnutrition-supplementary-information</a></p><p>Data on the number of cases of measles recorded in England for each of the last 12 months are not available in the format requested.</p><p> </p><p>The latest data available on the number of confirmed measles cases in England can be found here:</p><p><a href="https://www.gov.uk/government/publications/measles-mumps-and-rubella-laboratory-confirmed-cases-in-england-2017." target="_blank">https://www.gov.uk/government/publications/measles-mumps-and-rubella-laboratory-confirmed-cases-in-england-2017.</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 24/04/2018 15:30:00 answering member 4067 label Biography information for Steve Brine
tabling member	4036 label Biography information for Luciana Berger

886131

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescriptions: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the criteria are to qualify for a medical exemption certificate to allow people not to pay for their prescriptions.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	136326
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>A person can get free National Health Service prescriptions if they have one of the medical conditions listed in regulation 10 of the National Health Service (Charges for Drugs and Appliances) Regulations 2015, and hold a valid medical exemption certificate.</p><p> </p><p>Medical exemption certificates are issued on application to people who have:</p><p>- a permanent fistula (for example, a caecostomy, colostomy, laryngostomy or ileostomy) requiring continuous surgical dressing or requiring an appliance;</p><p>- a form of hypoadrenalism (for example, Addison's disease) for which specific substitution therapy is essential;</p><p>- diabetes insipidus or other forms of hypopituitarism;</p><p>- diabetes mellitus, except where treatment is by diet alone;</p><p>- Hypoparathyroidism;</p><p>- myasthenia gravis;</p><p>- myxoedema (hypothyroidism requiring thyroid hormone replacement);</p><p>- epilepsy requiring continuous anticonvulsive therapy; and</p><p>- a continuing physical disability that means the person can't go out without the help of another person – temporary disabilities do not count, even if they last for several months.</p><p> </p><p>They are also issued for people undergoing treatment for cancer:</p><p>- including the effects of cancer; or</p><p>- the effects of current or previous cancer treatment.</p><p> </p><p>Patients can apply for a medical exemption certificate by asking their doctor for Form FP92A.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 26/04/2018 10:13:10 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

886206

registered interest
date	18/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many women have joined the PrEP Impact trial to date.
tabling member constituency	Rotherham
tabling member printed	Sarah Champion
uin	136401
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>Since the start of the pre-exposure prophylaxis (PrEP) Impact trial in October 2017, the trial has recruited around 5,700 participants in 121 different clinics. Interim trial analysis, including reported gender of participants, will be available in winter 2018/19.</p><p> </p><p>To date, no assessment has been made of potential barriers to joining the PrEP Impact trial for women who are victims of domestic violence.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 136402 question first answered 26/04/2018 10:31:27 answering member 4067 label Biography information for Steve Brine
tabling member	4267 label Biography information for Sarah Champion